Global Hepatitis Report 2017

The report focuses on hepatitis B and C, which are responsible for 96% of all hepatitis mortality. It presents data along the five strategic directions (strategic information, interventions, equity, financing and innovation) – key pillars of the GHSS to facilitate monitoring of progress in countries, regions and globally, and to measure the impact of interventions on reducing new infections and
saving lives between 2015 and 2030.

Implementing Comprehensive HIV and HCV Programmes with People Who Inject Drugs

The tool describes how services can be designed and implemented to be accessible and acceptable to people who inject drugs. This requires respectful and ongoing engagement, and this publication gives particular attention to programmes run in close partnership with, or by, organizations of people who use drugs.

Symposium Panorama – HCV and PWID in Asia: Strategies for Treatment Scale-up

HCV prevalence in Asia and the Pacific varies between countries. HCV infection is due to unsterile medical injections (2 , 3) contaminated blood transfusions, (4) traditional cultural practices60 and, more recently, injecting drug use. (5) While iatrogenic transmission still occurs in some countries, transmission as the result of injecting drug use is increasing. (6)

Statement of HIV Constituency, CSO Forum on Asia-Pacific Forum on Sustainable Development (APFSD)

Statement of HIV Constituency during CSO Forum on Asia-Pacific Forum on Sustainable Development (APFSD) 2015

The beginnings of Harm Reduction

The beginnings of harm reduction in the context of drug use is difficult to clearly define, as harm reduction is now equated with HIV prevention for PWID and not as drug treatment. This is mainly the outcome of many years of concerted advocacy efforts promoting needle syringe exchange and methadone or buprenorphine substitution, much after the HIV epidemic had swept through PWID in many Asian countries.

A Strategy to halt and reverse the HIV epidemic among people who inject drugs in Asia and the Pacific 2010-2015

The present document, “A Strategy to Halt and Reverse the HIV Epidemic among People Who Inject Drugs in Asia and the Pacific, 2010–2015” can be a crucial tool. It is a call to action and a road map to ensure that the HIV and hepatitis epidemics among people who use drugs and their sexual partners in the Asia Pacific region will be halted. The strategy is designed to provide a regional framework, and it identifies issues and priorities and provides guidance to countries in the region for developing national strategic responses over the next six years. It shows the important link between halting the HIV epidemic and health and development, and will help countries achieve United Nations Millennium Development Goal 6 that calls for a halt and a reverse in the spread of HIV by 2015.